• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Cancer trials

Category

All
  • Pharma News
  • Health of Tomorrow
  • Opinion
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical Practice
  • Corona
  • Cancer trials
  • Healthy Living
  • Medical Research
  • Art on View
  • Viewpoints
  • Therapy
  • Health Innovation
  • Podcasts
  • Editor's pick
  • Publishing News
  • Special
  • BSMO Meeting 2021
  • Covid-19
  • EADO 2021

Cancer trials

TTFields concurrent with standard-of-care therapy in metastatic NSCLC following platinum failu...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • The Belgian Virtual Tumourbank: Residual tumour samples with high quality data
  • Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
  • Individualising radiation therapy decisions in breast cancer patients based on tumour-infiltrating lymphocytes and genomic biomarkers
  • Early-onset cancers: Incidence trends in Belgium, 2004–2020
  • Improving dysphagia care in head and neck cancer patients treated with radiotherapy
  • Journal Scan
  • New oncology reimbursements in Belgium
Cancer trials

Sustained overall survival benefit with avelumab maintenance in advanced urothelial carcinoma

Read more
Cancer trials

Niraparib improves radiographic PFS in prostate cancer patients harbouring a BRCA1/2 mu...

Read more
Cancer trials

Vorasidenib improves progression-free survival in patients with grade 2 IDH-mutant glio...

Read more
Cancer trials

Combining atezolizumab and cabozantinib does not yield clinical benefits in RCC patients

Read more
Cancer trials

Adjuvant cisplatin–gemcitabine as an alternative for cisplatin–fluorouracil in nasopharyng...

Read more
Cancer trials

Talazoparib plus enzalutamide delays disease progression in prostate cancer

Read more
Cancer trials

FDA approves talazoparib with enzalutamide for HRR-mutated mCRPC

Read more
Cancer trials

Pembrolizumab plus chemotherapy delays disease progression in endometrial cancer

Read more
1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023